These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 21762101)

  • 41. Hormonal therapies for new onset and relapsed depression during perimenopause.
    Worsley R; Davis SR; Gavrilidis E; Gibbs Z; Lee S; Burger H; Kulkarni J
    Maturitas; 2012 Oct; 73(2):127-33. PubMed ID: 22824374
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of serotonin in the pathophysiology of depression: as important as ever.
    Nemeroff CB; Owens MJ
    Clin Chem; 2009 Aug; 55(8):1578-9. PubMed ID: 19498050
    [No Abstract]   [Full Text] [Related]  

  • 43. Link between cutaneous infection, stress and depression.
    Jagmag T; Tirant M; Lotti T
    J Biol Regul Homeost Agents; 2017; 31(4):1037-1041. PubMed ID: 29254311
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Surprise neuroprotective potential of beta-lactam antibiotics.
    Senior K
    Drug Discov Today; 2005 Mar; 10(5):300. PubMed ID: 15749274
    [No Abstract]   [Full Text] [Related]  

  • 45. Circadian dimension and severity of depression.
    Courtet P; Olié E
    Eur Neuropsychopharmacol; 2012; 22 Suppl 3():S476-81. PubMed ID: 22959112
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New strategies in the development of antidepressants: towards the modulation of neuroplasticity pathways.
    Vidal R; Pilar-Cuéllar F; dos Anjos S; Linge R; Treceño B; Vargas VI; Rodriguez-Gaztelumendi A; Mostany R; Castro E; Diaz A; Valdizán EM; Pazos A
    Curr Pharm Des; 2011; 17(5):521-33. PubMed ID: 21375480
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The protective effects of β-lactam antibiotics in motor neuron disorders.
    Hedlund E
    Exp Neurol; 2011 Sep; 231(1):14-8. PubMed ID: 21693120
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The Post Stroke Depression Scale (PSDRS) as a tool for evaluation of depressed mood at an early stage after cerebral stroke].
    Przewoźnik DA; Rajtar-Zembaty AM; Bober-Płonka B; Starowicz-Filip A; Nowak R; Przewłocki R
    Przegl Lek; 2016; 73(9):648-51. PubMed ID: 29688673
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Post-stroke mood disorders.
    Robinson RG
    Hosp Pract (Off Ed); 1986 Apr; 21(4):83-9. PubMed ID: 3007550
    [No Abstract]   [Full Text] [Related]  

  • 50. Role of zinc in the development and treatment of mood disorders.
    Cope EC; Levenson CW
    Curr Opin Clin Nutr Metab Care; 2010 Nov; 13(6):685-9. PubMed ID: 20689416
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Endocannabinoid system dysfunction in mood and related disorders.
    Ashton CH; Moore PB
    Acta Psychiatr Scand; 2011 Oct; 124(4):250-61. PubMed ID: 21916860
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Combination of Zizyphus jujuba and silymarin showed better neuroprotective effect as compared to single agent in MCAo-induced focal cerebral ischemia in rats.
    Gupta S; Gupta YK
    J Ethnopharmacol; 2017 Feb; 197():118-127. PubMed ID: 27452658
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment options for acute depression in bipolar disorder.
    Bauer M; Ritter P; Grunze H; Pfennig A
    Bipolar Disord; 2012 May; 14 Suppl 2():37-50. PubMed ID: 22510035
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gut microbiota in autism and mood disorders.
    Mangiola F; Ianiro G; Franceschi F; Fagiuoli S; Gasbarrini G; Gasbarrini A
    World J Gastroenterol; 2016 Jan; 22(1):361-8. PubMed ID: 26755882
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Multiaxial evaluation of the pathophysiology of mood disorder and therapeutic mechanisms of clinical drugs by neuronal plasticity and neuronal load].
    Omata N; Mizuno T; Mitsuya H; Wada Y
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2013 Nov; 33(5-6):231-6. PubMed ID: 25069263
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Therapeutic effect of lisuride maleate on post-stroke depression].
    Hougaku H; Matsumoto M; Hata R; Handa N; Imaizumi M; Sugitani Y; Yoneda S; Etani H; Sueyoshi K; Kusunoki M
    Nihon Ronen Igakkai Zasshi; 1994 Jan; 31(1):52-9. PubMed ID: 8158872
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Depression and ischemic heart disease.
    O'connor CM; Gurbel PA; Serebruany VL
    Am Heart J; 2000 Oct; 140(4 Suppl):63-9. PubMed ID: 11011350
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mood swings.
    Mandavilli A
    Nat Med; 2004 Oct; 10(10):1010-2. PubMed ID: 15459689
    [No Abstract]   [Full Text] [Related]  

  • 59. α-blockers, antibiotics and anti-inflammatories have a role in the management of chronic prostatitis/chronic pelvic pain syndrome.
    Thakkinstian A; Attia J; Anothaisintawee T; Nickel JC
    BJU Int; 2012 Oct; 110(7):1014-22. PubMed ID: 22471591
    [TBL] [Abstract][Full Text] [Related]  

  • 60. From depression to neurodegeneration and heart failure: re-examining the potential of MAO inhibitors.
    Deftereos SN; Dodou E; Andronis C; Persidis A
    Expert Rev Clin Pharmacol; 2012 Jul; 5(4):413-25. PubMed ID: 22943121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.